Zoom’s CEO agrees with Bill Gates, Jensen Huang, and Jamie Dimon: A 3-day workweek is coming soon thanks to AI

Written and edited by the WorldPing NewsdeskPublished Updated Original reporting: Fortune
Zoom’s CEO agrees with Bill Gates, Jensen Huang, and Jamie Dimon: A 3-day workweek is coming soon thanks to AIWorldPing
Image via Fortune.

What happened

Zoom leader Eric Yuan admitted the technology will erase some human jobs—but those who keep their jobs will enjoy fewer working days.

Key facts

  • Reported by Fortune and published Sun, 20 Sep 2026 13:24:12 UTC.

Why it matters

Economic releases and corporate results feed directly into rate expectations, currency moves and equity pricing, so the detail here often matters more to markets than the headline itself.

What to watch next

  • Revisions to the initial figures once fuller data is released
  • How rate expectations and index futures respond
  • Guidance or commentary from the companies and policymakers involved

Coverage timeline

When each newsroom published on this story, oldest first — all times UTC.

  1. Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away faster

  2. Zoom’s CEO agrees with Bill Gates, Jensen Huang, and Jamie Dimon: A 3-day workweek is coming soon thanks to AI

  3. Billionaire Melinda French Gates once revealed she refused to fund her Gen Z daughter’s startup—despite being worth over $34 billion

  4. Bernie Sanders is right about the four-day workweek – but wrong about how to get there

Sources

The original report was published by Fortune. WorldPing does not claim that reporting — this page summarises and contextualises it.

Read the full report at Fortune

Follow the story

Living hubs that keep updating as this story develops.

Related WorldPing coverage

ScienceDaily
WorldPing
ScienceDaily

Hidden gut defect that may explain why IBD keeps coming back

Researchers have uncovered a hidden molecular warning sign of inflammatory bowel disease (IBD) that can linger even when patients feel well and appear to be in remission.

Brief by WorldPing · Original reporting by ScienceDaily